HSBC Holdings’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $719K | Sell |
195,782
-5,451
| -3% | -$20K | ﹤0.01% | 1541 |
|
|
2025
Q1 | $604K | Buy |
201,233
+39,023
| +24% | +$117K | ﹤0.01% | 1569 |
|
|
2024
Q4 | $546K | Buy |
162,210
+2,610
| +2% | +$8.78K | ﹤0.01% | 1739 |
|
|
2024
Q3 | $539K | Buy |
159,600
+1,491
| +0.9% | +$5.03K | ﹤0.01% | 1620 |
|
|
2024
Q2 | $518K | Sell |
158,109
-13,259
| -8% | -$43.4K | ﹤0.01% | 1617 |
|
|
2024
Q1 | $692K | Sell |
171,368
-9,003
| -5% | -$36.4K | ﹤0.01% | 1574 |
|
|
2023
Q4 | $554K | Buy |
180,371
+168,273
| +1,391% | +$517K | ﹤0.01% | 1600 |
|
|
2023
Q3 | $36K | Buy |
+12,098
| New | +$36K | ﹤0.01% | 2126 |
|
|
2022
Q2 | – | Sell |
-11,717
| Closed | -$83K | – | 2781 |
|
|
2022
Q1 | $83K | Hold |
11,717
| – | – | ﹤0.01% | 2765 |
|
|
2021
Q4 | $105K | Buy |
+11,717
| New | +$105K | ﹤0.01% | 2642 |
|